Term
|
Definition
|
|
Term
|
Definition
Sympathomimetic
Bronchodilator |
|
|
Term
|
Definition
Selective beta 2 agonist
Stimulates adrenergic receptors of the sympathomimetic nervous system
Results in smooth muscle relaxation in the bronchial tree and peripheral vasculature. |
|
|
Term
|
Definition
COPD, Asthma
Prevention of exercise induced bronchospasm
Reactive airway disorders |
|
|
Term
|
Definition
Known prior hypersensitivity
Reaction to albuterol
Tachycardia
Dysrhythmias
|
|
|
Term
| Adverse reactions/side effects |
|
Definition
Dysrhythmias
Chest pain
Palpitations
Pulmonary edema
Tachycardia |
|
|
Term
|
Definition
Tricyclic antidepressants
Beta blockers
May potentiate hypokalemia caused by diuretics |
|
|
Term
| Dosage and administration |
|
Definition
Adult:
2.5 MG. Dilute in 0.5 ml of 0.5% solution for inhalation with 2.5 ml normal saline in nebulizer and administer over 10 to 15 minutes.
MDI 1 TO 2 inhalation (90 to 120 mcg)
Pediatric:
< 20 kg: 1.25 MG dose via handheld nebulizer or mask over 20 minutes
>20 kg: 2.5 MG dose via handheld nebulizer or mask over 20 minutes.
Repeat once in 20 minutes |
|
|
Term
|
Definition
Onset:
5 - 15 minutes
Peak:
30 minutes - 2 hours
Duration:
3 - 4 hours |
|
|
